Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Shanghai EpimAb Biotherapeutics Co., Ltd.
Scientific Title
A Phase I/II Trial of EMB-02, a Bi-specific Antibody Against PD-1 and LAG-3, in Patients With Advanced Solid Tumors